Swiss-MadeN° 02 — Metabolic research
Retatrutide60MG
Triple GIP / GLP-1 / GCG receptor agonist
Retatrutide is an investigational 39-amino-acid peptide studied as a triple agonist of the GIP, GLP-1 and glucagon (GCG) receptors. Its multi-receptor profile places it at the frontier of current metabolic research.
Neochemi Retatrutide is supplied as a lyophilized peptide, HPLC-verified to ≥99% purity and released only after batch-level analytical review.
| Purity | ≥99% (HPLC verified) |
|---|---|
| Content | 60 mg per vial |
| Presentation | Lyophilized peptide · 1 vial |
| CAS number | 2381089-83-2 |
| Molecular formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular weight | 4731.3 g/mol |
| Sequence | 39 amino acids |
| Storage | −20 °C, protected from light |
| Origin | Switzerland · Swiss-Made |
Mechanism of interest
Three receptors.
One molecule.
Retatrutide adds the glucagon receptor to the GIP and GLP-1 pathways — a three-receptor profile investigated in ongoing clinical research programs.
Conceptual visual representation. Not a depiction of molecular structure.Explore the collection
